Valsartan Dosing for Hypertension Management

Combination Therapy and Blood Pressure Targets

The European Society of Cardiology recommends combining valsartan with a dihydropyridine calcium channel blocker or thiazide diuretic as first-line therapy for most patients with confirmed hypertension (BP ≥140/90 mmHg) 1
Fixed-dose single-pill combinations are recommended to improve adherence 1
If blood pressure remains uncontrolled on two-drug combination, escalate to three-drug therapy with a RAS blocker, dihydropyridine calcium channel blocker, and thiazide/thiazide-like diuretic 1
Target treated systolic blood pressure to 120-129 mmHg in most adults to reduce cardiovascular risk 1

Do not combine valsartan with an ACE inhibitor, as this increases the risk of hyperkalemia and renal dysfunction 2
Monitor serum potassium and creatinine within 1-2 weeks after initiating or increasing doses, particularly in patients with baseline renal impairment 2

Take valsartan once daily at the most convenient time to establish a habitual pattern and improve adherence 1

The American Heart Association recommends targeting blood pressure <140/90 mmHg for patients without comorbidities, and <130 mmHg for patients with existing cardiovascular disease or high cardiovascular risk, according to the Hypertension guideline society 3
For high-risk patients, including those with diabetes or chronic kidney disease, the Hypertension guideline society suggests targeting systolic blood pressure <130 mmHg 3

The Hypertension guideline society recommends follow-up monthly after initiation or dose changes until blood pressure target is reached, then every 3-5 months for patients under control 3
The Hypertension guideline society advises against delaying treatment for extensive testing, and laboratory screening for comorbidities should not delay initiation of antihypertensive therapy 3